Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3022057 | 0.92 | CAPN1 (0.43) | CAPN1MEN1KMT2AMAPTLMNA | |
| SCHEMBL3021484 | 0.88 | CAPN1 (0.43) | CAPN1MDM2PPARGKDM4EALDH1A1 | |
| SCHEMBL3031709 | 0.86 | CAPN1 (0.45) | CAPN1MEN1KMT2AMDM2GLA | |
| SCHEMBL27797712 | 0.85 | CAPN1 (0.40) | CAPN1MEN1KMT2AMDM2GLA | |
| SCHEMBL3025192 | 0.83 | CAPN1 (0.47) | CAPN1MEN1KMT2AMDM2GLA | |
| SCHEMBL3017368 | 0.82 | AR (0.33) | KCNA5KDM4EALDH1A1AR | |
| SCHEMBL3796902 | 0.81 | KCNA5 (0.32) | MEN1KMT2AKCNA5AR | |
| SCHEMBL3024183 | 0.79 | CAPN1 (0.42) | CAPN1MDM2MAPTLMNAKDM4E | |
| SCHEMBL3023698 | 0.79 | CAPN1 (0.42) | CAPN1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL3021942 | 0.77 | MEN1 (0.33) | MEN1KMT2AKCNA5AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190794-A1 | Herbicidally Active Composition | BASF SE (DE) | 2010-07-29 | — | — | US | claimed |
| EP-2157856-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | Basf Se (DE) | 2010-03-03 | — | — | EP | claimed |
| WO-2008152074-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | BASF SE (DE) | 2008-12-18 | — | — | WO | claimed |
| US-20100190794-A1 | Herbicidally Active Composition | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
| EP-2157856-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | Basf Se (DE) | 2010-03-03 | — | — | EP | disclosed |
| WO-2008152074-A1 | HERBICIDALLY EFFECTIVE COMPOSITION | BASF SE (DE) | 2008-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190794-A1 | Herbicidally Active Composition | ECI1, ACLY, SQOR | CAPN1 3690/4885MEN1 4521/4885KMT2A 2213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.